Correlation Between Evolus and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evolus and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and ANI Pharmaceuticals, you can compare the effects of market volatilities on Evolus and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and ANI Pharmaceuticals.
Diversification Opportunities for Evolus and ANI Pharmaceuticals
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Evolus and ANI is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Evolus i.e., Evolus and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evolus and ANI Pharmaceuticals
Given the investment horizon of 90 days Evolus Inc is expected to generate 1.48 times more return on investment than ANI Pharmaceuticals. However, Evolus is 1.48 times more volatile than ANI Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about 0.05 per unit of risk. If you would invest 718.00 in Evolus Inc on August 27, 2024 and sell it today you would earn a total of 542.00 from holding Evolus Inc or generate 75.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evolus Inc vs. ANI Pharmaceuticals
Performance |
| Timeline |
| Evolus Inc |
| ANI Pharmaceuticals |
Evolus and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evolus and ANI Pharmaceuticals
The main advantage of trading using opposite Evolus and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |